Annual Working Capital
$25.58 M
+$2.20 M+9.39%
31 December 2023
Summary:
Oncolytics Biotech annual working capital is currently $25.58 million, with the most recent change of +$2.20 million (+9.39%) on 31 December 2023. During the last 3 years, it has risen by +$1.25 million (+5.13%). ONCY annual working capital is now -37.55% below its all-time high of $40.96 million, reached on 31 December 2010.ONCY Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$11.29 M
-$6.60 M-36.88%
30 September 2024
Summary:
Oncolytics Biotech quarterly working capital is currently $11.29 million, with the most recent change of -$6.60 million (-36.88%) on 30 September 2024. Over the past year, it has dropped by -$14.70 million (-56.56%). ONCY quarterly working capital is now -78.76% below its all-time high of $53.14 million, reached on 31 March 2011.ONCY Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCY Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.4% | -56.6% |
| 3 y3 years | +5.1% | -70.5% |
| 5 y5 years | +199.4% | +31.6% |
ONCY Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -22.7% | +9.4% | -70.5% | at low |
| 5 y | 5 years | -22.7% | +451.3% | -73.5% | +143.3% |
| alltime | all time | -37.5% | +727.0% | -78.8% | +174.7% |
Oncolytics Biotech Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.29 M(-36.9%) |
| June 2024 | - | $17.88 M(-17.5%) |
| Mar 2024 | - | $21.67 M(-15.3%) |
| Dec 2023 | $25.58 M(+9.4%) | $25.58 M(-1.5%) |
| Sept 2023 | - | $25.98 M(+21.5%) |
| June 2023 | - | $21.39 M(-9.0%) |
| Mar 2023 | - | $23.50 M(+0.5%) |
| Dec 2022 | $23.39 M(-29.4%) | $23.39 M(-7.4%) |
| Sept 2022 | - | $25.26 M(-11.7%) |
| June 2022 | - | $28.61 M(-13.1%) |
| Mar 2022 | - | $32.93 M(-0.5%) |
| Dec 2021 | $33.11 M(+36.1%) | $33.11 M(-13.6%) |
| Sept 2021 | - | $38.32 M(-10.1%) |
| June 2021 | - | $42.63 M(+5.6%) |
| Mar 2021 | - | $40.36 M(+65.9%) |
| Dec 2020 | $24.33 M(+424.4%) | $24.33 M(+19.9%) |
| Sept 2020 | - | $20.29 M(-8.3%) |
| June 2020 | - | $22.12 M(+5.9%) |
| Mar 2020 | - | $20.88 M(+349.9%) |
| Dec 2019 | $4.64 M(-45.7%) | $4.64 M(-45.9%) |
| Sept 2019 | - | $8.58 M(+14.0%) |
| June 2019 | - | $7.52 M(-7.4%) |
| Mar 2019 | - | $8.12 M(-4.9%) |
| Dec 2018 | $8.54 M(-14.6%) | $8.54 M(-23.7%) |
| Sept 2018 | - | $11.21 M(-9.4%) |
| June 2018 | - | $12.37 M(+65.7%) |
| Mar 2018 | - | $7.47 M(-25.4%) |
| Dec 2017 | $10.01 M(+30.1%) | $10.01 M(+6.2%) |
| Sept 2017 | - | $9.42 M(-11.9%) |
| June 2017 | - | $10.70 M(+104.6%) |
| Mar 2017 | - | $5.23 M(-32.0%) |
| Dec 2016 | $7.69 M(-55.9%) | $7.69 M(-33.9%) |
| Sept 2016 | - | $11.63 M(-17.4%) |
| June 2016 | - | $14.08 M(-8.9%) |
| Mar 2016 | - | $15.45 M(-11.4%) |
| Dec 2015 | $17.45 M(+52.4%) | $17.45 M(-14.1%) |
| Sept 2015 | - | $20.32 M(-15.0%) |
| June 2015 | - | $23.90 M(+13.6%) |
| Mar 2015 | - | $21.04 M(+83.7%) |
| Dec 2014 | $11.45 M(-43.8%) | $11.45 M(-10.2%) |
| Sept 2014 | - | $12.75 M(-14.5%) |
| June 2014 | - | $14.91 M(-6.8%) |
| Mar 2014 | - | $16.01 M(-21.4%) |
| Dec 2013 | $20.36 M(+40.9%) | $20.36 M(-22.4%) |
| Sept 2013 | - | $26.24 M(-17.5%) |
| June 2013 | - | $31.81 M(-15.5%) |
| Mar 2013 | - | $37.64 M(+160.4%) |
| Dec 2012 | $14.45 M | $14.45 M(-35.4%) |
| Sept 2012 | - | $22.37 M(-26.0%) |
| June 2012 | - | $30.24 M(-26.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $41.03 M(+43.8%) |
| Dec 2011 | $28.53 M(-30.3%) | $28.53 M(-24.7%) |
| Sept 2011 | - | $37.88 M(-19.0%) |
| June 2011 | - | $46.75 M(-12.0%) |
| Mar 2011 | - | $53.14 M(+29.7%) |
| Dec 2010 | $40.96 M(+41.6%) | $40.96 M(+129.5%) |
| Sept 2010 | - | $17.85 M(-13.8%) |
| June 2010 | - | $20.72 M(-20.1%) |
| Mar 2010 | - | $25.93 M(-10.3%) |
| Dec 2009 | $28.92 M(+295.6%) | $28.92 M(+347.8%) |
| Sept 2009 | - | $6.46 M(-19.2%) |
| June 2009 | - | $8.00 M(+94.5%) |
| Mar 2009 | - | $4.11 M(-43.8%) |
| Dec 2008 | $7.31 M(-67.9%) | $7.31 M(-24.0%) |
| Sept 2008 | - | $9.62 M(-31.2%) |
| June 2008 | - | $13.99 M(-26.2%) |
| Mar 2008 | - | $18.97 M(-16.7%) |
| Dec 2007 | $22.78 M(+3.3%) | $22.78 M(-14.1%) |
| Sept 2007 | - | $26.52 M(-5.9%) |
| June 2007 | - | $28.17 M(-3.4%) |
| Mar 2007 | - | $29.17 M(+32.3%) |
| Dec 2006 | $22.05 M(-34.8%) | $22.05 M(-19.0%) |
| Sept 2006 | - | $27.21 M(-9.7%) |
| June 2006 | - | $30.14 M(-3.1%) |
| Mar 2006 | - | $31.09 M(-8.1%) |
| Dec 2005 | $33.82 M(+22.2%) | $33.82 M(+22.0%) |
| Sept 2005 | - | $27.72 M(+8.7%) |
| June 2005 | - | $25.50 M(-9.0%) |
| Mar 2005 | - | $28.01 M(+1.2%) |
| Dec 2004 | $27.68 M(+79.0%) | $27.68 M(+52.6%) |
| Sept 2004 | - | $18.14 M(-4.1%) |
| June 2004 | - | $18.92 M(+34.1%) |
| Mar 2004 | - | $14.11 M(-8.8%) |
| Dec 2003 | $15.47 M(+239.8%) | $15.47 M(+35.6%) |
| Sept 2003 | - | $11.41 M(+18.8%) |
| June 2003 | - | $9.60 M(+130.0%) |
| Mar 2003 | - | $4.18 M(-8.3%) |
| Dec 2002 | $4.55 M(-43.1%) | $4.55 M(-0.3%) |
| Sept 2002 | - | $4.57 M(-27.3%) |
| June 2002 | - | $6.28 M(-10.2%) |
| Mar 2002 | - | $6.99 M(-12.5%) |
| Dec 2001 | $7.99 M(-30.2%) | $7.99 M(-9.0%) |
| Sept 2001 | - | $8.79 M(-16.0%) |
| June 2001 | - | $10.45 M(-1.6%) |
| Mar 2001 | - | $10.62 M(-7.3%) |
| Dec 2000 | $11.45 M(+270.3%) | $11.45 M(-2.5%) |
| Sept 2000 | - | $11.75 M(+8.0%) |
| June 2000 | - | $10.87 M(-9.7%) |
| Mar 2000 | - | $12.04 M |
| Dec 1999 | $3.09 M | - |
FAQ
- What is Oncolytics Biotech annual working capital?
- What is the all time high annual working capital for Oncolytics Biotech?
- What is Oncolytics Biotech annual working capital year-on-year change?
- What is Oncolytics Biotech quarterly working capital?
- What is the all time high quarterly working capital for Oncolytics Biotech?
- What is Oncolytics Biotech quarterly working capital year-on-year change?
What is Oncolytics Biotech annual working capital?
The current annual working capital of ONCY is $25.58 M
What is the all time high annual working capital for Oncolytics Biotech?
Oncolytics Biotech all-time high annual working capital is $40.96 M
What is Oncolytics Biotech annual working capital year-on-year change?
Over the past year, ONCY annual working capital has changed by +$2.20 M (+9.39%)
What is Oncolytics Biotech quarterly working capital?
The current quarterly working capital of ONCY is $11.29 M
What is the all time high quarterly working capital for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly working capital is $53.14 M
What is Oncolytics Biotech quarterly working capital year-on-year change?
Over the past year, ONCY quarterly working capital has changed by -$14.70 M (-56.56%)